Ron Squarer
Presidente en ADC THERAPEUTICS SA .
Fortuna: 7 M $ al 30/04/2024
Cargos activos de Ron Squarer
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
TRAVERE THERAPEUTICS, INC. | Director/Miembro de la Junta | 12/04/2017 | - |
Independent Dir/Board Member | 12/04/2017 | - | |
DECIPHERA PHARMACEUTICALS, INC. | Independent Dir/Board Member | 04/12/2019 | - |
Presidente | 03/08/2023 | - | |
Director/Miembro de la Junta | 04/12/2019 | 03/08/2023 | |
ADC THERAPEUTICS SA | Presidente | 01/04/2020 | - |
Deciphera Pharmaceuticals LLC
Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Director/Miembro de la Junta | 01/12/2019 | - |
Historial de carrera de Ron Squarer
Antiguos cargos conocidos de Ron Squarer.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ARRAY TECHNOLOGIES, INC. | Director/Miembro de la Junta | 26/04/2012 | 01/08/2019 |
Director Ejecutivo | 26/04/2012 | 01/08/2019 | |
HOSPIRA, INC. | Corporate Officer/Principal | 03/11/2010 | 01/02/2012 |
Mayne Pharma Ltd.
Mayne Pharma Ltd. Pharmaceuticals: OtherHealth Technology Mayne Pharma Ltd. manufactures pharmaceutical products. It distributes generic injectables for the oncology market. The company's competitors include Sandoz, Bedford Labs, and Ebewe. It was founded in November 2005 and is headquartered in Melbourne, Australia. | Corporate Officer/Principal | 01/01/2006 | 01/01/2007 |
Smithkline Beecham Plc
Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Corporate Officer/Principal | - | - |
Formación de Ron Squarer.
University of California, Berkeley | Undergraduate Degree |
Kellogg School of Management | Masters Business Admin |
Estadísticas
Internacional
Estados Unidos | 8 |
Australia | 2 |
Reino Unido | 2 |
Operativa
Director/Board Member | 4 |
Corporate Officer/Principal | 3 |
Independent Dir/Board Member | 2 |
Sectorial
Health Technology | 9 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
TRAVERE THERAPEUTICS, INC. | Health Technology |
DECIPHERA PHARMACEUTICALS, INC. | Health Technology |
ADC THERAPEUTICS SA | Health Technology |
Empresas privadas | 5 |
---|---|
Mayne Pharma Ltd.
Mayne Pharma Ltd. Pharmaceuticals: OtherHealth Technology Mayne Pharma Ltd. manufactures pharmaceutical products. It distributes generic injectables for the oncology market. The company's competitors include Sandoz, Bedford Labs, and Ebewe. It was founded in November 2005 and is headquartered in Melbourne, Australia. | Health Technology |
Smithkline Beecham Plc
Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Health Technology |
Hospira, Inc.
Hospira, Inc. Pharmaceuticals: MajorHealth Technology Hospira, Inc. provides injectable drugs and infusion technologies. It offers drugs, IV sets and clinical integration, infusion pumps, clinical software and implementation services. The company was founded on September 16, 2003 and is headquartered in Lake Forest, IL. | Health Technology |
Array BioPharma, Inc.
Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
Deciphera Pharmaceuticals LLC
Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Ron Squarer
- Experiencia